ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $791,000 | +93.9% | 170,404 | +108.9% | 0.00% | – |
Q4 2021 | $408,000 | -60.5% | 81,571 | -4.9% | 0.00% | -100.0% |
Q3 2021 | $1,034,000 | +6.9% | 85,818 | +87.8% | 0.00% | 0.0% |
Q2 2021 | $967,000 | -39.9% | 45,703 | -20.3% | 0.00% | 0.0% |
Q1 2021 | $1,608,000 | +44.5% | 57,343 | +34.0% | 0.00% | 0.0% |
Q4 2020 | $1,113,000 | -31.4% | 42,794 | -1.9% | 0.00% | 0.0% |
Q3 2020 | $1,622,000 | -45.9% | 43,642 | -25.3% | 0.00% | -50.0% |
Q2 2020 | $2,996,000 | +97.5% | 58,384 | +21.3% | 0.00% | +100.0% |
Q1 2020 | $1,517,000 | -26.9% | 48,113 | +38.2% | 0.00% | -50.0% |
Q4 2019 | $2,076,000 | +106.0% | 34,822 | +26.7% | 0.00% | +100.0% |
Q3 2019 | $1,008,000 | -12.0% | 27,486 | +11.6% | 0.00% | 0.0% |
Q2 2019 | $1,146,000 | +25.5% | 24,639 | +8.4% | 0.00% | 0.0% |
Q1 2019 | $913,000 | -2.8% | 22,736 | +11.3% | 0.00% | 0.0% |
Q4 2018 | $939,000 | +5.0% | 20,420 | +1.4% | 0.00% | 0.0% |
Q3 2018 | $894,000 | +8.2% | 20,141 | -4.4% | 0.00% | 0.0% |
Q2 2018 | $826,000 | -75.0% | 21,079 | -53.9% | 0.00% | -66.7% |
Q1 2018 | $3,305,000 | +11.7% | 45,693 | +1.7% | 0.00% | 0.0% |
Q4 2017 | $2,959,000 | +19.7% | 44,943 | -8.9% | 0.00% | 0.0% |
Q3 2017 | $2,473,000 | +6.5% | 49,335 | -1.6% | 0.00% | 0.0% |
Q2 2017 | $2,321,000 | +34.8% | 50,148 | +2.8% | 0.00% | 0.0% |
Q1 2017 | $1,722,000 | +697.2% | 48,762 | +183.2% | 0.00% | – |
Q4 2016 | $216,000 | -26.3% | 17,218 | -18.7% | 0.00% | – |
Q3 2016 | $293,000 | -30.9% | 21,167 | -50.7% | 0.00% | -100.0% |
Q2 2016 | $424,000 | +142.3% | 42,903 | +315.0% | 0.00% | – |
Q1 2016 | $175,000 | -58.8% | 10,337 | +98.7% | 0.00% | -100.0% |
Q2 2015 | $425,000 | +3.7% | 5,203 | +17.5% | 0.00% | 0.0% |
Q1 2015 | $410,000 | – | 4,428 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |